Table 1 Patient demographics
HER-2 negative | ||
|---|---|---|
ER+ and/or PgR+ | ER− PgR− | |
n | 18 | 2 |
Age, years, median (range) | 52 (42–76) | 56.5 (48–65) |
Race, n (%) | ||
White | 15 (83.3) | 2 (100) |
Black | 1 (5.6) | 0 |
Asian | 1 (5.6) | 0 |
Multiple | 1 (5.6) | 0 |
Weight, kg, median (range) | 68.25 (55.3–97.2) | 68.10 (56.7–79.5) |
Clinical tumor stage | ||
IA | 4 (22.2) | 1 (50) |
IB | 3 (16.7) | 0 |
T2N0M0 (IIa) | 7 (38.9) | 1 (50) |
T2N1M0 (IIb) | 2 (11.1) | 0 |
T3N0M0 (IIb) | 2 (11.1) | 0 |